Yu, Lu
Zhang, Zhen
Yi, HeQing
Wang, Jin
Li, Junyi
Wang, Xiaofeng
Bai, Hui
Ge, Hong
Zheng, Xiaoli
Ni, Jianjiao
Qi, Haoran
Guan, Yong
Xu, Wengui
Zhu, Zhengfei
Xing, Ligang
Dekker, Andre
Wee, Leonard
Traverso, Alberto
Ye, Zhaoxiang
Yuan, Zhiyong
Funding for this research was provided by:
National Natural Science Foundation of China (82172674)
Natural Science Foundation of Tianjin Municipal Science and Technology Bureau (20JCYBJC00090)
Cancer Precision Radiotherapy Spark Program of China International Medical Foundation (2019-N-11-26)
Construction Project of Cancer Precision Diagnosis and Drug Treatment Technology, TMUCIH (ZLJZZDYYWZL08)
Wu Jieping Medical Foundation (320.6750.2020-10-96)
Article History
Received: 17 June 2023
Accepted: 10 January 2024
First Online: 22 January 2024
Declarations
:
: The study was approved be ethical committee of Tianjin Medical University Cancer Institute and Hospital.
: The authors give their permission for the submission.
: The authors declare no competing interests.